We are live on ! Find out more
OCA

OpenArc Corporate Advisory Portfolio holdings

AUM $8.41B
This Fund
S&P 500
This Quarter Est. Return
+16.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.41B
AUM Growth
+$1.42B
Cap. Flow
+$539M
Cap. Flow %
6.42%
Top 10 Hldgs %
33.46%
Holding
833
New
117
Increased
380
Reduced
255
Closed
44
Avg Time Held
1.6 quarters
Top 10 Avg Time Held
1.6 quarters
Top 20 Avg Time Held
1.7 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.82%
2 Technology 16.24%
3 Consumer Discretionary 5.63%
4 Healthcare 3.98%
5 Industrials 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PSA icon
676
Public Storage
PSA
$54B
$253K ﹤0.01%
796
-51
-6% -$15.6K
2026 Q1
1 quarter
CHRW icon
677
C.H. Robinson
CHRW
$16.3B
$253K ﹤0.01%
1,344
-24
-2% -$4.26K
2025 Q4
2 quarters
GWW icon
678
W.W. Grainger
GWW
$61.5B
$252K ﹤0.01%
+185
New +$228K
2026 Q2
0 quarters
HAS icon
679
Hasbro
HAS
$13.4B
$251K ﹤0.01%
3,037
-525
-15% -$47.2K
2025 Q4
2 quarters
JLL icon
680
Jones Lang LaSalle
JLL
$13.7B
$250K ﹤0.01%
+808
New +$251K
2026 Q2
0 quarters
CPAY icon
681
Corpay
CPAY
$26.1B
$250K ﹤0.01%
751
+11
+1% +$3.65K
2025 Q4
2 quarters
DFLV icon
682
Dimensional US Large Cap Value ETF
DFLV
$7.14B
$250K ﹤0.01%
+6,314
New +$242K
2026 Q2
0 quarters
SOUN icon
683
SoundHound AI
SOUN
$2.21B
$249K ﹤0.01%
38,494
-45,105
-54% -$349K
2026 Q1
1 quarter
USMV icon
684
iShares MSCI USA Min Vol Factor ETF
USMV
$23.9B
$247K ﹤0.01%
2,565
– –
2026 Q1
1 quarter
BXP icon
685
Boston Properties
BXP
$9.51B
$247K ﹤0.01%
+3,730
New +$223K
2026 Q2
0 quarters
ESS icon
686
Essex Property Trust
ESS
$17.4B
$246K ﹤0.01%
843
+1
+0.1% +$269
2025 Q4
2 quarters
CRWV icon
687
CoreWeave
CRWV
$44.3B
$245K ﹤0.01%
+2,457
New +$265K
2026 Q2
0 quarters
TWLO icon
688
Twilio
TWLO
$43.4B
$244K ﹤0.01%
+1,184
New +$210K
2026 Q2
0 quarters
TKO icon
689
TKO Group
TKO
$12.7B
$244K ﹤0.01%
+1,211
New +$236K
2026 Q2
0 quarters
PBR icon
690
Petrobras
PBR
$164B
$244K ﹤0.01%
+15,081
New +$295K
2026 Q2
0 quarters
TDY icon
691
Teledyne Technologies
TDY
$28.4B
$243K ﹤0.01%
364
-23
-6% -$14.5K
2026 Q1
1 quarter
DOV icon
692
Dover
DOV
$25.7B
$240K ﹤0.01%
1,071
-32
-3% -$6.97K
2026 Q1
1 quarter
SECU icon
693
iShares Securitized Income Active ETF
SECU
$891M
$239K ﹤0.01%
+4,796
New +$239K
2026 Q2
0 quarters
NEM icon
694
Newmont
NEM
$123B
$239K ﹤0.01%
2,557
+705
+38% +$76.8K
2026 Q1
1 quarter
R icon
695
Ryder
R
$9.11B
$239K ﹤0.01%
+905
New +$221K
2026 Q2
0 quarters
NOK icon
696
Nokia
NOK
$55.4B
$238K ﹤0.01%
+17,940
New +$231K
2026 Q2
0 quarters
CYTK icon
697
Cytokinetics
CYTK
$8.73B
$238K ﹤0.01%
+2,792
New +$200K
2026 Q2
0 quarters
IVT icon
698
InvenTrust Properties
IVT
$2.34B
$237K ﹤0.01%
+6,692
New +$220K
2026 Q2
0 quarters
DKS icon
699
Dick's Sporting Goods
DKS
$13.5B
$237K ﹤0.01%
1,043
-600
-37% -$133K
2025 Q4
2 quarters
IJJ icon
700
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.46B
$236K ﹤0.01%
1,600
-24
-1% -$3.4K
2026 Q1
1 quarter

Similar funds

OpenArc Corporate Advisory's Q2 2026 Portfolio in Review

As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.

By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 57% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.

  • OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
  • OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
  • OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
  • OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
  • OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
  • OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
  • OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.